-
Posted by
Two Blokes Jun 14 -
Filed in
Stock
-
8 views
Coloplast is a global leader in specialized intimate healthcare, with strong innovation, high margins, and a defensible moat in core segments. Despite a 20% share price drop, I see upside potential, but only at a conservative 25x P/E due to risks in commoditized segments and M&A. Current fundamentals are solid: strong organic growth, robust dividend, and on-track 2025E results, but margin expansion is likely capped.
